Home
|
Help
|
Contact
Sign in
WPRIM Management System>
DCMS
>
Korean Journal of Blood Transfusion
>
2015
>
26
Volume:
26
1. Application of a Grey Zone for HCV and HIV Immunoassays for Blood Donor Screening: Is It still Necessary?.
Page:204—212
2. Residual Risk of Transfusion-Transmitted Infection with Hepatitis C Virus since the Introduction of Nucleic Acid Testing in Korea.
Page:193—203
3. Gene Frequency of Human Neutrophil Alloantigen-3 in the Korean Population.
Page:185—192
4. Human Neutrophil Alloantigen-3a Alloimmunization among Pregnant Korean Women.
Page:174—184
5. Survey on the Usage of Leukocyte Reduced and Irradiated Blood Components in Korea (2007~2013).
Page:159—173
6. Reporting System of Transfusion Adverse Reaction Using Electronic Medical Records Data.
Page:152—158
7. Analysis Survey on Changes in Hospital Blood Donation Center and Satisfaction Level with the Korean Red Cross.
Page:142—151
8. Evaluation of Clinical Parameters and Symptoms in Healthy Donors for Granulocyte Collection.
Page:132—141
9. Correlation between the Severity of Bone Pain and the Amount of CD34+ Cells after Peripheral Blood Stem Cell Mobilization.
Page:123—131
10. Biological Meaning of the Histo-Blood Group Antigens Composed of Sugar Chains.
Page:103—122
11. Retraction: Experience of Therapeutic Plasma Exchange in Patients with Severe Fever with Thrombocytopenia Syndrome.
Page:81—81
12. Therapeutic Plasma Exchange for a Patient with Severe Cold Agglutinin Disease.
Page:75—80
13. A Clinical Experience of Massive Transfusion in a Patient with Cardiac Arrest Resulting from Abdominal Aortic Aneurysm Rupture.
Page:70—74
14. Report on External Proficiency Testing for the ABO and D Blood Group Typing Tests in Blood Centers (2014).
Page:60—69
15. Unexpected Antibody Screening Tests Including Di(a) in Patients with a History of Multiple Packed Red Cell Transfusion.
Page:54—59
16. Performance Evaluation of Unexpected Antibody Screening Test Including Di(a) Cell Using 3% Surgiscreen Sub-Code D in Korean Multi-Transfused Patients.
Page:47—53
17. An Update of Maximum Surgical Blood Order Schedule in Elective Surgery.
Page:38—46
18. A Feasibility Study for Cryopreserving Peripheral Blood Stem Cell Collects at High Cell Concentration.
Page:26—37
19. Comparison of Serum-Free Media in RBC Differentiation from Human Hematopoietic Stem Cells.
Page:18—25
20. A Choice and Precautions of Replacement Fluids for Therapeutic Plasma Exchange.
Page:9—17
21. Transfusion Strategy and Laboratory Update on the DEL Variant.
Page:1—8
22. Correction: Performance Evaluation of Unexpected Antibody Screening Test Including Dia Cell Using 3% Surgiscreen Sub-Code D in Korean Multi-Transfused Patients.
Page:326—326
23. A System for Cryopreservation of Rare Red Blood Cell Units; Right Time to Start.
Page:323—325
24. A Case of Washed Platelet Transfusion in a Patient with History of Recurrent Transfusion Reaction.
Page:316—322
25. A Case Report of Transfusion-Related Acute Lung Injury Induced in the Patient with HLA Antibody after Fresh Frozen Plasma Transfusion.
Page:309—315
26. Consideration of the Improvement of the Confirmatory Assay for the Anti-HTLV Positive Blood Donation.
Page:300—308
27. Korean Red Cross HLA-Matched Platelet Donor Registry.
Page:291—299
28. Assessment of Serum Ferritin Levels in Plateletpheresis Donors.
Page:282—290
29. Evaluation of Two Noninvasive Hemoglobin Testing Devices.
Page:273—281
30. An Experience of Patient Involvement in the Pre-Transfusion Checking Process: A Single Center Study.
Page:266—272
31. Evaluation of the Automated Immunohematology Analyzer ORTHO VISION for ABO Antibody Titration.
Page:257—265
32. Analysis of Unexpected Antibodies Detected in Children: A Single Center Study for 7 Years.
Page:249—256
33. Emerging Infectious Disease and Safety of Blood Components.
Page:235—248